These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8132440)

  • 61. Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.
    Poyurovsky M; Meerovich I; Weizman A
    Int Clin Psychopharmacol; 1995 Jun; 10(2):111-4. PubMed ID: 7673653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
    Schittecatte M; Dumont F; Machowski R; Fontaine E; Cornil C; Mendlewicz J; Wilmotte J
    Psychiatry Res; 2002 Jan; 109(1):1-8. PubMed ID: 11850045
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.
    Escalona R; Canive JM; Calais LA; Davidson JR
    Depress Anxiety; 2002; 15(1):29-33. PubMed ID: 11816050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.
    Ashina S; Bendtsen L; Jensen R
    Pain; 2004 Mar; 108(1-2):108-14. PubMed ID: 15109513
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 Jan; 35(1):23-8. PubMed ID: 12607287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.
    Franchini L; Gasperini M; Perez J; Smeraldi E; Zanardi R
    J Clin Psychiatry; 1997 Mar; 58(3):104-7. PubMed ID: 9108811
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.
    Dell'Agnello G; Ceravolo R; Nuti A; Bellini G; Piccinni A; D'Avino C; Dell'Osso L; Bonuccelli U
    Clin Neuropharmacol; 2001; 24(4):221-7. PubMed ID: 11479393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study.
    Hohagen F; Winkelmann G; Rasche-Rüchle H; Hand I; König A; Münchau N; Hiss H; Geiger-Kabisch C; Käppler C; Schramm P; Rey E; Aldenhoff J; Berger M
    Br J Psychiatry Suppl; 1998; (35):71-8. PubMed ID: 9829029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A double-blind group comparative trial of mianserin and diazepam in depressed outpatients.
    Hamouz W; Pinder RM; Stulemeijer SM
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Mar; 13(2):79-83. PubMed ID: 7433519
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L; Jensen R
    Neurology; 2004 May; 62(10):1706-11. PubMed ID: 15159466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
    Kato M; Fukuda T; Wakeno M; Fukuda K; Okugawa G; Ikenaga Y; Yamashita M; Takekita Y; Nobuhara K; Azuma J; Kinoshita T
    Neuropsychobiology; 2006; 53(4):186-95. PubMed ID: 16874005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study.
    Emamzadehfard S; Kamaloo A; Paydary K; Ahmadipour A; Zeinoddini A; Ghaleiha A; Mohammadinejad P; Zeinoddini A; Akhondzadeh S
    Psychiatry Clin Neurosci; 2016 Aug; 70(8):332-41. PubMed ID: 27106362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.